Genome silencer therapy leading to ‘regression’ of cardiac amyloid load on cardiovascular magnetic resonance: a case report

BACKGROUND: Hereditary or variant transthyretin amyloidosis (ATTRv) is a progressive disease manifesting with neuropathy and/or cardiomyopathy. An early and accurate diagnosis of cardiac amyloidosis is a pre-requisite for timely and appropriate patient management, including anti-amyloid therapies, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Florian, Anca, Bietenbeck, Michael, Hüsing-Kabar, Anna, Schilling, Matthias, Schmidt, Hartmut H, Yilmaz, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Grand Round
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603242/
https://www.ncbi.nlm.nih.gov/pubmed/34816083
http://dx.doi.org/10.1093/ehjcr/ytab415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603242/
https://www.ncbi.nlm.nih.gov/pubmed/34816083
http://dx.doi.org/10.1093/ehjcr/ytab415

Ejemplares similares